rs61978626
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_207361.6(FREM2):c.7535G>A(p.Arg2512His) variant causes a missense change. The variant allele was found at a frequency of 0.00103 in 1,551,594 control chromosomes in the GnomAD database, including 3 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.00057 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 2 hom. )
Consequence
FREM2
NM_207361.6 missense
NM_207361.6 missense
Scores
1
8
6
Clinical Significance
Conservation
PhyloP100: 4.92
Publications
7 publications found
Genes affected
FREM2 (HGNC:25396): (FRAS1 related extracellular matrix 2) This gene encodes an integral membrane protein containing numerous CSPG (chondroitin sulfate proteoglycan element) repeats and Calx-beta domains. The encoded protein localizes to the basement membrane, forming a ternary complex that plays a role in epidermal-dermal interactions. This protein is important for the integrity of skin and renal epithelia. Mutations in this gene are associated with Fraser syndrome. [provided by RefSeq, Apr 2014]
FREM2 Gene-Disease associations (from GenCC):
- Fraser syndrome 2Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
- Fraser syndrome 1Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- renal agenesis, unilateralInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Fraser syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000573 (86/150130) while in subpopulation NFE AF = 0.000991 (67/67626). AF 95% confidence interval is 0.0008. There are 1 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR,AD gene
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_207361.6. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.000573 AC: 86AN: 150026Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
86
AN:
150026
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000477 AC: 120AN: 251370 AF XY: 0.000493 show subpopulations
GnomAD2 exomes
AF:
AC:
120
AN:
251370
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00107 AC: 1505AN: 1401464Hom.: 2 Cov.: 35 AF XY: 0.00107 AC XY: 744AN XY: 698296 show subpopulations
GnomAD4 exome
AF:
AC:
1505
AN:
1401464
Hom.:
Cov.:
35
AF XY:
AC XY:
744
AN XY:
698296
show subpopulations
African (AFR)
AF:
AC:
7
AN:
33200
American (AMR)
AF:
AC:
2
AN:
42308
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
25428
East Asian (EAS)
AF:
AC:
0
AN:
39688
South Asian (SAS)
AF:
AC:
20
AN:
85030
European-Finnish (FIN)
AF:
AC:
4
AN:
51332
Middle Eastern (MID)
AF:
AC:
0
AN:
5702
European-Non Finnish (NFE)
AF:
AC:
1422
AN:
1061126
Other (OTH)
AF:
AC:
48
AN:
57650
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
73
146
218
291
364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000573 AC: 86AN: 150130Hom.: 1 Cov.: 32 AF XY: 0.000423 AC XY: 31AN XY: 73274 show subpopulations
GnomAD4 genome
AF:
AC:
86
AN:
150130
Hom.:
Cov.:
32
AF XY:
AC XY:
31
AN XY:
73274
show subpopulations
African (AFR)
AF:
AC:
11
AN:
40856
American (AMR)
AF:
AC:
5
AN:
14966
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3462
East Asian (EAS)
AF:
AC:
0
AN:
5134
South Asian (SAS)
AF:
AC:
1
AN:
4652
European-Finnish (FIN)
AF:
AC:
1
AN:
10142
Middle Eastern (MID)
AF:
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
AC:
67
AN:
67626
Other (OTH)
AF:
AC:
1
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
6
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
10
ExAC
AF:
AC:
49
EpiCase
AF:
EpiControl
AF:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
2
-
Isolated cryptophthalmia;C4540036:Fraser syndrome 2 (2)
-
2
-
not specified (2)
1
-
-
Congenital anomaly of kidney and urinary tract (1)
-
1
-
Fraser syndrome 2 (1)
-
1
-
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
T
MetaRNN
Uncertain
D
MetaSVM
Benign
T
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Benign
T
Sift4G
Uncertain
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.